In addition, PD-L1+ B cells have been identified within IgA+ B cells in mice bearing liver tumors and have been proposed to mediate resistance to chemotherapy in prostate cancer, which can be overturned by PD-L1 blockade (50, 442). Here, CD274 is linked to prostate carcinoma.